Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Open Access
- 1 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (5) , 691-700
Abstract
BACKGROUND: Fibroblast growth factor (FGF) 21 is an endocrine factor actively involved in glucose and lipid metabolism in rodents. However, little is known about its physiological function and regulation in humans. This study investigated the diurnal changes in circulating FGF21 concentrations and their association with other metabolic markers in both obese and lean individuals. METHODS: A total of 36 volunteers were assigned to 2 groups. One group received 3 standardized meals and another group was fasted for 24 h. Blood samples were drawn every 30 min throughout a 24-h period. Circulating FGF21 concentrations were measured with an in-house chemiluminescence immunoassay. The effects of fatty acids on hepatic production of FGF21 were determined by using real-time PCR. RESULTS: In both the fasting and standardized meals groups, circulating FGF21 began to rise at midnight, reaching a peak in the early morning and then declining to basal concentrations early in the afternoon. Baseline concentrations of circulating FGF21 were much higher in obese individuals than in lean individuals (P < 0.05). However, the magnitude of the nocturnal rise in circulating FGF21 was significantly blunted in obese individuals. The 24-h oscillatory pattern of circulating FGF21 resembled that of free fatty acids and cortisol, but was opposite to the patterns of insulin and glucose. Unsaturated fatty acids induced time-dependent expression of FGF21 mRNA in human hepatocytes. CONCLUSIONS: These findings support the role of FGF21 as an important metabolic regulator that integrates the circadian rhythm with energy homeostasis in humans. Diurnal rhythms of circulating FGF21 could be partly caused by the oscillation of free fatty acids.Keywords
Funding Information
- Collaborative Research Fund (HKU3/09C)
- National 973 Project of China (2011CB504001)
- National Basic Research Program of China (2011CB504004)
This publication has 35 references indexed in Scilit:
- Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor αJournal of Biological Chemistry, 2010
- Hepatic FGF21 Expression Is Induced at Birth via PPARα in Response to Milk Intake and Contributes to Thermogenic Activation of Neonatal Brown FatCell Metabolism, 2010
- PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axisProceedings of the National Academy of Sciences, 2009
- Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to KetosisEndocrinology, 2009
- Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by HyperinsulinemiaDiabetes, 2009
- FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation responseProceedings of the National Academy of Sciences, 2009
- Fasted to Fed Trafficking of Fatty Acids in Human Adipose Tissue Reveals a Novel Regulatory Step for Enhanced Fat StorageThe Journal of Clinical Endocrinology & Metabolism, 2009
- Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21Diabetes, 2009
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005